| Catalog | name | Description | price |
|---|---|---|---|
| R-R-3575 | GP531 CAS No.142344-87-4 | GP531/CAS No.142344-87-4 is a potent, second-generation adenosine regulating agent, is pharmacologically silent under basal conditions but increases localized endogenous adenosine during ischemia. | price> |
| R-R-3576 | Adenosine receptor antagonist 3 CAS No.2400864-80-2 | Adenosine receptor antagonist 3/CAS No.2400864-80-2 is a potent antagonist of adenosine receptor. Adenosine receptor antagonist 3 has the potential for the research of cancer disease (extracted from patent WO2019233994A1, compound 1). | price> |
| R-R-3577 | Inupadenant hydrochloride CAS No.2411004-22-1 | Inupadenant (EOS-850) hydrochloride/CAS No.2411004-22-1 is an orally active, highly selective A2A receptor antagonist. Inupadenant hydrochloride is not brain-penetrant. Inupadenant hydrochloride has potent anti-tumor activity. | price> |
| R-C-1878 | AZD-7594 CAS:1196509-60-0 | AZD-7594(AZ13189620)is an inhaled selective glucocorticoid receptor(GCCR)modulator.AZD-7594 is in phase II clinical trials by AstraZeneca for the treatment of mild to moderate asthma.It is also in phase I clinical trials for the treatment of chronic obstructive pulmonary disorder(COPD). | price> |
| R-R-3578 | Sipagladenant CAS No.858979-50-7 | Sipagladenant (Compound I)/CAS No.858979-50-7 is an orally active adenosine receptor A2A inverse agonist. Sipagladenant can be used in frontal lobe dysfunction research. | price> |
| R-R-3579 | SDZ-WAG994 CAS No.130714-47-5 | SDZ-WAG994 (WAG-994)/CAS No.130714-47-5 is a stable, long-acting, selective and orally active A1-adenosine receptor agonist with a KD of 23 nM. SDZ-WAG994 can be used for the research of atrial fibrillation. | price> |
| R-R-3580 | Alloxazine CAS No.490-59-5 | Alloxazine/CAS No.490-59-5 is a selective A2b antagonist. Alloxazine completely block 5 N-Ethylcarboxamido adenosine (NECA)-mediated cyclic AMP accumulation with an IC50 of 2.9 μM. Alloxazine can be used for the research of cancer. | price> |
| R-R-3581 | ST 1535 CAS No.496955-42-1 | ST 1535/CAS No.496955-42-1 is a potent and orally active A2A adenosine receptor antagonist. ST 1535 shows antiparkinsonian activity and antitremorigenic effects. ST 1535 has the potential for the research of Parkinson disease. | price> |
| R-R-3582 | Binodenoson CAS No.144348-08-3 | Binodenoson (MRE-0470)/CAS No.144348-08-3 is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging. | price> |
| R-C-1883 | SSR240612 CAS:464930-42-5 | SSR240612 is a potent,and orally active specific non-peptide bradykinin B1 receptor antagonist,with Kis of 0.48 nM and 0.73nM for B1 kinin receptors of human fibroblast MRC5 and HEK cells expressing human B1 receptors,481nM and 358 nM for B2 receptors of guinea pig ileum membranes and CHO cells expressing human B1 receptor,respectively. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


